ClinicalTrials.Veeva

Menu

Cannabidiol in Youth Alcohol Use Disorder

Medical University of South Carolina (MUSC) logo

Medical University of South Carolina (MUSC)

Status and phase

Completed
Phase 2

Conditions

Alcohol Use Disorder

Treatments

Drug: Cannabidiol

Study type

Interventional

Funder types

Other

Identifiers

NCT05317546
Pro00119770

Details and patient eligibility

About

The goal of this study is to test cannabidiol (CBD) as a potentially effective candidate medication for youth alcohol use disorder (AUD). To accomplish this goal, this study will use a randomized, double-blind, within-subjects crossover design. In counterbalanced order, 50 youth (ages 16-22) will receive 600 mg of CBD or placebo three hours before a neuroimaging and behavioral assessment paradigm. The total amount of time the participant will be in the study is approximately one month.

Enrollment

36 patients

Sex

All

Ages

16 to 22 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Age 16 to 22. Does or does not drink alcohol.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

36 participants in 2 patient groups

Cannabidiol, Then Placebo
Experimental group
Treatment:
Drug: Cannabidiol
Placebo, Then Cannabidiol
Experimental group
Treatment:
Drug: Cannabidiol

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Cori Herring, BS; Lindsay Squeglia, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems